To "B" or not to "B": efficacy of a neonatal hepatitis B vaccination program to prevent primary liver cancer and end-stage liver disease

Affiliations

Comment

Rasika Karnik et al. Gastroenterology. 2015 May.

. 2015 May;148(5):1073-5.

doi: 10.1053/j.gastro.2015.03.037. Epub 2015 Mar 27.

¹ Department of Internal Medicine, UT Southwestern Medical Center, Dallas, Texas.

No abstract available

Comment in

Reply: To PMID 25549238.
Qu C, Zhang Y. Qu C, et al. Gastroenterology. 2015 May;148(5):1075. doi: 10.1053/j.gastro.2015.03.036. Epub 2015 Mar 27. Gastroenterology. 2015. PMID: 25824363 No abstract available.

Efficacy of neonatal HBV vaccination on liver cancer and other liver diseases over 30-year follow-up of the Qidong hepatitis B intervention study: a cluster randomized controlled trial.
Qu C, Chen T, Fan C, Zhan Q, Wang Y, Lu J, Lu LL, Ni Z, Huang F, Yao H, Zhu J, Fan J, Zhu Y, Wu Z, Liu G, Gao W, Zang M, Wang D, Dai M, Hsia CC, Zhang Y, Sun Z. Qu C, et al. PLoS Med. 2014 Dec 30;11(12):e1001774. doi: 10.1371/journal.pmed.1001774. eCollection 2014 Dec. PLoS Med. 2014. PMID: 25549238 Free PMC article. Clinical Trial.